STOCK TITAN
  1. Home
  2. News
  3. OGI

Organigram Holdings Inc. - OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings stock.

OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.

OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.

OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.

Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.

OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.

News

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment

Rhea-AI Summary
Organigram Holdings Inc. (OGI) announces a $2 million minority investment in Open Book Extracts, a leading hemp-derived extracts and products provider. The investment aims to expand Organigram's footprint in the U.S. market and explore potential product launches, research collaborations, and international opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.35%
Tags
none
-
News

Organigram Receives Health Canada’s Final Redetermination on Jolts

Rhea-AI Summary
Organigram Holdings Inc. announced that Health Canada has reclassified its Edison Jolts lozenge products as edible cannabis despite evidence supporting ingestible classification. The decision follows a court ruling on procedural fairness. Organigram is disappointed and is evaluating next steps.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.35%
Tags
none
-
News

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty

Rhea-AI Summary
Organigram Holdings Inc. supports the Standing Committee on Finance's recommendation to adjust the excise duty framework for the cannabis industry. Licensed producers currently pay up to 35% of revenue in excise duties, hindering competitiveness and innovation. The proposed 10% ad valorem rate reduction could significantly benefit the sector's sustainability and support government objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
none
News

Organigram Reports First Quarter Fiscal 2024 Results

Rhea-AI Summary
Organigram Holdings Inc. achieved positive cash flow and solidified its market position in Canada, announcing a $124.6 million strategic investment from BAT. They improved margins, maintained market positions, and introduced new products. Despite a decline in net revenue, the company showed positive Adjusted EBITDA and cash flow. Key financial metrics and balance sheet data highlight the company's financial standing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.55%
Tags
earnings
-
News

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

Rhea-AI Summary
Organigram Holdings Inc. (OGI) will report earnings for its first quarter fiscal 2024 on February 13, 2024. The conference call to discuss the results will be held at 8:00 am Eastern Time on the same day. The registration link for the call and webcast details are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
conferences earnings
-
News

Organigram Completes First Shipment to Germany, Extending its International Reach

Rhea-AI Summary
Organigram Holdings Inc. (OGI) has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, as part of its multi-year agreement. The company will provide high-quality, indoor-grown dried flower product to Sanity Group and grant strain exclusivity on certain genetics. The inaugural shipment contains Organigram’s exceptional Super G Citra strain. This expansion into international markets reflects the company's commitment to quality, consistency, and consumer focus.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
News

Organigram Announces the First Tranche Closing from BAT Investment

Rhea-AI Summary
Organigram Holdings Inc. (OGI) has closed the first tranche of a C$124,559,674 strategic equity investment by BT DE Investments Inc., a subsidiary of British American Tobacco plc. The Investor acquired 12,893,175 common shares at C$3.2203 per share, with the remaining shares to be issued in two further tranches. The investment will be used to create a strategic investment pool, named Jupiter, targeting emerging cannabis opportunities for geographic expansion. Organigram's 10 years of experience and successful cannabis investments position it for global growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.51%
Tags
none
-
News

Organigram Announces Appointment of Karina Gehring to Board of Directors

Rhea-AI Summary
Organigram Holdings Inc. appoints Karina Gehring to the Board of Directors, representing British American Tobacco plc. Gehring brings over 25 years of marketing and trade experience and is expected to provide valuable insights and expertise to the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.71%
Tags
management
-
News

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

Rhea-AI Summary
Organigram Holdings Inc. announced the results of its annual general and special meeting of shareholders, including the election of directors, committee composition, appointment of auditor, and shareholder approval of investment and articles of amendment. KPMG LLP was approved as the Company's auditor, and a C$124.6 million follow-on strategic equity investment was approved by the shareholders. The Investment is expected to close on or around January 23, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.71%
Tags
none
News

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Rhea-AI Summary
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced a special meeting to approve a $124.6 million investment from BAT at $3.2203/share and the creation of the 'Jupiter' strategic investment pool. The investment is subject to approval by shareholders at the meeting to be held on January 18, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.09%
Tags
none

FAQ

What is OrganiGram Holdings Inc.?

OrganiGram Holdings Inc. is a Canadian company engaged in the production of indoor-grown cannabis for medical patients and adult recreational users.

What types of cannabis products does OrganiGram offer?

OrganiGram offers a range of cannabis products under brands such as Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, Trailblazer, Tremblant Cannabis, and Laurentian.

Where is OrganiGram Holdings Inc. based?

OrganiGram Holdings Inc. is based in Atlantic Canada.

How can I contact OrganiGram's client services team?

You can contact OrganiGram's client services team by calling 1-855-961-9420.

Is OrganiGram involved in research and development?

Yes, OrganiGram places a strong emphasis on research and development to enhance its cultivation techniques and product offerings.

What regulations does OrganiGram operate under?

OrganiGram operates under Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Is OrganiGram Holdings Inc. publicly traded?

Yes, OrganiGram Holdings Inc. is publicly traded under the symbol OGI.

Where can I find more information about OrganiGram?

You can find more information about OrganiGram by visiting their website at www.organigram.ca.

What makes OrganiGram's cannabis products unique?

OrganiGram's cannabis products are unique due to their high quality, organically grown nature, and diverse brand portfolio.

Has OrganiGram recently expanded its product lineup?

Yes, OrganiGram has recently added Tremblant Cannabis and the artisanal craft brand, Laurentian to its product lineup.

Stock OGI logo
Organigram Holdings Inc.

Nasdaq:OGI

OGI Rankings

#3965 Ranked by Market Cap
N/A Ranked by Dividends

OGI Stock Data

167.89M
103.37M
27.32%
14.87%
3.79%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Toronto